Physician profile
Donald Walker
NPI 1386639110
$2,939.27
in general payments reported to CMS, 2019-2025
19 companies · $69.83 in 2025
The $69.83 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $358 · 2021: $583 · 2022: $402 · 2023: $512 · 2024: $549 · 2025: $69.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921 · Entertainment: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.19 |
| Entertainment | $210.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $531.16 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $351.89 | 2020-2024 | Cequa |
| Optos, INC. | $328.72 | 2021-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $308.10 | 2019-2024 | Hydrus Microstent |
| Novartis Pharmaceuticals Corporation | $267.97 | 2019-2023 | |
| Johnson & Johnson Vision Care, INC. | $188.60 | 2022-2023 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $188.23 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $178.57 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $161.73 | 2019-2021 | |
| Abbvie INC. | $145.83 | 2023-2025 | Lumigan, Durysta |
| Oyster Point Pharma, INC. | $82.79 | 2022-2023 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $58.79 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $30.36 | 2024 | Acthar |
| Bausch & Lomb Americas INC. | $28.65 | 2023-2024 | Vyzulta, Lotemax Sm, Zylet |
| Ivantis, INC | $24.94 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $24.62 | 2021-2022 | |
| Biotissue Holdings INC. | $15.16 | 2024 | |
| Harrow Eye, LLC | $13.54 | 2024 | Vevye |
| Rxsight INC | $9.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.